Clinicians only want the information they need to make treatment decisions, rather than advice on what actions they should take, the survey found.
The recent CMS coverage determination did not make any mention of beta-amyloid PET imaging that is necessary for both diagnosing Alzheimer’s and monitoring the effectiveness of related treatments.
The findings support adopting F-18 DCFPyL PET/CT as the standard of care for prostate cancer staging, authors of a new Scientific Reports paper concluded.
Rather than administering radiolabeled glucose for exams, imagers give patients a small amount of a harmless glucose solution that is said to be equivalent to a can of a carbonated drink.
Difficulty obtaining PET/CT scans was reported by 55% of respondents, with 21% citing this as the greatest barrier in treating classic Hodgkin lymphoma.
Many new imaging solutions were on display at the world's largest health informatics conference, held at McCormick Place in Chicago.
Radiologist David Gruen, MD, discusses some of the overarching themes from the Healthcare Information Management Systems Society's annual meeting.
End-users of various radiology IT systems offer their assessment of the software in the annual KLAS Research 2023 Best in KLAS report.
Do clinicians want radiologists' management advice? Interviews shed some light on 'unwanted' recommendations
Will PET imaging be covered alongside new Alzheimer's drugs? CMS dodges topic in new coverage decision
PSMA-PET a more cost-effective option for patients long-term compared to standard prostate imaging
Radioactive substances unnecessary in new method for measuring brain glucose metabolism
Accessibility, reimbursement and other issues limit uptake of PET/CT among oncologists, survey reveals
MRI and PET findings could guide treatment of lingering concussion symptoms
Abnormalities of the thalamus could be to blame for persistent symptoms in the months following a concussion, according to new research.
Experts release new appropriate use criteria for lymphoscintigraphy in sentinel node mapping
The AUC includes a total of 32 clinical scenarios that have been grouped into four categories of cancer: breast, skin, cancer of other sites and lymphedema.
Imaging required to monitor effects of new Alzheimer's drug could inhibit its uptake
Leqembi can cause amyloid-related imaging abnormalities (ARIA), which must be assessed on imaging.